PEPTIDE CORPUS

Immune & Antimicrobial

Bactericidal/Permeability-Increasing Protein (BPI)

Last updated

Strongest sourceRecombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with s… (randomised human trial)

Dosing on file unverified

rBPI21: Phase I/II/III trials; dosing variable by study; well-tolerated

Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.

Literature on file 3

Identity

UniProt
P17213

Notes unverified prose

Phase I/II/III completed (meningococcemia, trauma); rBPI21; NCT00462904; rBPI21 Phase I/II/III; Phase III meningococcemia

Not on file 8

8 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.

Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.